Relationship between chronic rhinosinusitis exacerbation frequency and asthma control
- PMID: 28963721
- DOI: 10.1002/lary.26901
Relationship between chronic rhinosinusitis exacerbation frequency and asthma control
Abstract
Objectives/hypothesis: To determine the association between the frequency of acute chronic rhinosinusitis (CRS) exacerbations (AECRS) and the degree of asthma control in asthmatic CRS patients.
Study design: Cross-sectional study.
Methods: We prospectively recruited 108 asthmatic CRS patients as participants. Asthma control was assessed using the Asthma Control Test (ACT). The frequency of AECRS was assessed using three previously described indirect metrics for AECRS: the frequency of patient-reported sinus infections, CRS-related antibiotics use, and CRS-related oral corticosteroids use in the last 3 months. CRS symptom severity was measured using the 22-item Sinonasal Outcome Test (SNOT-22). Associations between ACT score and metrics for AECRS were performed using linear regression while controlling for clinical and demographic characteristics, including SNOT-22 score.
Results: ACT score was significantly and negatively associated with the frequency of patient-reported sinus infections (adjusted linear regression coefficient [β] = -1.2, 95% confidence interval [CI]: -2.3 to -0.1, P = .033), CRS-related antibiotics courses (adjusted β = -1.4, 95% CI: -2.3 to -0.5, P = .004), and CRS-related oral corticosteroid courses (adjusted β = -1.5, 95% CI: -2.5 to -0.5, P = .004) in the last 3 months, independent of characteristics including SNOT-22 score. Poor asthma control could be detected using one or more sinus infections (70.6% sensitivity, 47.3% specificity), CRS-related antibiotics (50.0% sensitivity, 73.0% specificity), or CRS-related oral corticosteroids (58.8% sensitivity, 71.6% specificity) in the last 3 months.
Conclusions: AECRS are negatively associated with the level of asthma control in asthmatic CRS patients, independent of CRS symptom severity. These results highlight AECRS as a distinct clinical manifestation of CRS that should be routinely assessed in CRS patients.
Level of evidence: 2c. Laryngoscope, 128:1033-1038, 2018.
Keywords: 22-item Sinonasal Outcome Test; Chronic rhinosinusitis; acute exacerbations; antibiotics; asthma control; oral corticosteroids.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Clinical Traits Characterizing an Exacerbation-Prone Phenotype in Chronic Rhinosinusitis.Otolaryngol Head Neck Surg. 2019 Nov;161(5):890-896. doi: 10.1177/0194599819865474. Epub 2019 Jul 30. Otolaryngol Head Neck Surg. 2019. PMID: 31359836
-
Chronic rhinosinusitis exacerbations are differentially associated with lost productivity based on asthma status.Rhinology. 2018 Dec 1;56(4):323-329. doi: 10.4193/Rhin18.033. Rhinology. 2018. PMID: 30042985
-
Reciprocal Predictive Accuracy of Sinonasal Symptom Severity, Nasal Endoscopy, and Frequency of Past Chronic Rhinosinusitis Exacerbations.Otolaryngol Head Neck Surg. 2018 Oct;159(4):766-773. doi: 10.1177/0194599818774741. Epub 2018 May 15. Otolaryngol Head Neck Surg. 2018. PMID: 29759028
-
Acute exacerbations of chronic rhinosinusitis: The current state of knowledge.Laryngoscope Investig Otolaryngol. 2022 Jul 20;7(4):935-942. doi: 10.1002/lio2.857. eCollection 2022 Aug. Laryngoscope Investig Otolaryngol. 2022. PMID: 36000029 Free PMC article. Review.
-
Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review.J Otolaryngol Head Neck Surg. 2020 Aug 18;49(1):62. doi: 10.1186/s40463-020-00459-w. J Otolaryngol Head Neck Surg. 2020. PMID: 32811568 Free PMC article.
Cited by
-
Periostin as a Biomarker of Allergic Inflammation in Atopic Bronchial Asthma and Allergic Rhinitis (a Pilot Study).Sovrem Tekhnologii Med. 2021;12(5):37-45. doi: 10.17691/stm2020.12.5.04. Epub 2020 Oct 28. Sovrem Tekhnologii Med. 2021. PMID: 34796003 Free PMC article.
-
Type 2 immunity-driven diseases: Towards a multidisciplinary approach.Clin Exp Allergy. 2021 Dec;51(12):1538-1552. doi: 10.1111/cea.14029. Epub 2021 Oct 15. Clin Exp Allergy. 2021. PMID: 34617355 Free PMC article. Review.
-
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis.Allergy Asthma Proc. 2021 Sep 1;42(5):417-424. doi: 10.2500/aap.2021.42.210058. Allergy Asthma Proc. 2021. PMID: 34474711 Free PMC article.
-
A cost utility analysis for the management of acute exacerbations of chronic rhinosinusitis.Int Forum Allergy Rhinol. 2025 Feb;15(2):109-119. doi: 10.1002/alr.23452. Epub 2024 Sep 20. Int Forum Allergy Rhinol. 2025. PMID: 39302214 Free PMC article.
-
Chronic rhinosinusitis disease burden is associated with asthma-related emergency department usage.Eur Arch Otorhinolaryngol. 2021 Jan;278(1):93-99. doi: 10.1007/s00405-020-06259-2. Epub 2020 Aug 4. Eur Arch Otorhinolaryngol. 2021. PMID: 32749608
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials